These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Post exercise myalgias as presentation form of dystrophinopathy]. Kleinsteuber K; Rocco P; Herrera L; Vainzof M; Birke ME; Yáñez M; Flandes A; Zatz M; de Carvallo P; Avaria MA Rev Med Chil; 2000 Jul; 128(7):772-7. PubMed ID: 11050839 [TBL] [Abstract][Full Text] [Related]
3. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory]. Navarro C Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784 [TBL] [Abstract][Full Text] [Related]
4. Utility of dystrophin and utrophin staining in childhood muscular dystrophy. Sundaram C; Vydehi B; Meena K; Murthy J Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426 [TBL] [Abstract][Full Text] [Related]
5. Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies. Vainzof M; Passos-Bueno MR; Man N; Zatz M Am J Med Genet; 1995 Sep; 58(4):305-9. PubMed ID: 8533838 [TBL] [Abstract][Full Text] [Related]
6. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene]. Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443 [TBL] [Abstract][Full Text] [Related]
7. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030 [TBL] [Abstract][Full Text] [Related]
8. Utrophin is a regeneration-associated protein transiently present at the sarcolemma of regenerating skeletal muscle fibers in dystrophin-deficient hypertrophic feline muscular dystrophy. Lin S; Gaschen F; Burgunder JM J Neuropathol Exp Neurol; 1998 Aug; 57(8):780-90. PubMed ID: 9720493 [TBL] [Abstract][Full Text] [Related]
9. A 2-bp deletion in exon 74 of the dystrophin gene does not clearly induce muscle weakness. Kimura S; Ito K; Ueno H; Ikezawa M; Takeshima Y; Yoshioka K; Ozasa S; Nakamura K; Nomura K; Matsukura M; Mitsui K; Matsuo M; Miike T Brain Dev; 2009 Feb; 31(2):169-72. PubMed ID: 18430534 [TBL] [Abstract][Full Text] [Related]
10. Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia. Saengpattrachai M; Ray PN; Hawkins CE; Berzen A; Banwell BL Pediatr Neurol; 2006 Aug; 35(2):145-9. PubMed ID: 16876015 [TBL] [Abstract][Full Text] [Related]
11. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]